Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India High Court Orders Glenmark Response To MSD Appeal By May 22

This article was originally published in PharmAsia News

Executive Summary

A two-judge panel of the Delhi High Court ordered Glenmark to respond by May 22 as Merck Sharp and Dohme continues the appeal process against the India drug maker's generics of Januvia (sitagliptin) and Janumet (metformin/sitagliptin) diabetes drugs.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC084010

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel